United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 4 minute read General business news Redrow deal pays off—Barratt Redrow beats expectations with strong growth Barratt Redrow PLC has reported a solid financial performance for the first half of its 2025 fiscal year,… byPallavi MadhirajuFebruary 15, 2025